A significantly reduced risk of bladder cancer recurrence was found in patients simultaneously carrying the GSTP1 AA and GSTO1 CC genotypes, when compared to patients carrying other combinations of genotypes (Fig. 4) (HR = 0.21, 95% CI = 0.08–0.56). Here, GSTO1 is linked to urinary bladder cancer.